L310-0464 Screening compound: 6-chloro-4-[(5-ethyl-1,2,4-oxadiazol-3-yl)methyl]-7-[(4-methylpiperidin-1-yl)sulfonyl]-3,4-dihydro-2H-1,4-benzoxazin-3-one

L310-0464 Screening compound: 6-chloro-4-[(5-ethyl-1,2,4-oxadiazol-3-yl)methyl]-7-[(4-methylpiperidin-1-yl)sulfonyl]-3,4-dihydro-2H-1,4-benzoxazin-3-one
L310-0464 Screening compound: 6-chloro-4-[(5-ethyl-1,2,4-oxadiazol-3-yl)methyl]-7-[(4-methylpiperidin-1-yl)sulfonyl]-3,4-dihydro-2H-1,4-benzoxazin-3-one alternative view

Chemical Structure Depiction of ChemDiv screening compound L310-0464
6-chloro-4-[(5-ethyl-1,2,4-oxadiazol-3-yl)methyl]-7-[(4-methylpiperidin-1-yl)sulfonyl]-3,4-dihydro-2H-1,4-benzoxazin-3-one

Available from 1 mg

Formats:

  • Glass Vials (4ml Glass Vials VWR #97047-678)
  • 96-tube racks (Matrix #4247 96-well 1.4ml sealed with capmats, empty cols 1 & 12, 100uL of 10mM)

Shiptime: 1 week worldwide delivery in most cases

Compound Identifiers

ChemDiv Compound ID

L310-0464

Molecular Formula

C19H23ClN4O5S (C19 H23 ClN4 O5 S)

Compound Name

6-chloro-4-[(5-ethyl-1,2,4-oxadiazol-3-yl)methyl]-7-[(4-methylpiperidin-1-yl)sulfonyl]-3,4-dihydro-2H-1,4-benzoxazin-3-one

IUPAC name

6-chloro-4-[(5-ethyl-124-oxadiazol-3-yl)methyl]-7-[(4-methylpiperidin-1-yl)sulfonyl]-34-dihydro-2H-14-benzoxazin-3-one

SMILES

CCc1nc(CN(C(COc2c3)=O)c2cc(Cl)c3S(N2CCC(C)CC2)(=O)=O)no1

InChI

InChI=1S/C19H23ClN4O5S/c1-3-18-21-17(22-29-18)10-24-14-8-13(20)16(9-15(14)28-11-19(24)25)30(26,27)23-6-4-12(2)5-7-23/h8-9,12H,3-7,10-11H2,1-2H3

InChI Key

VOIGLDUFVHXFOH-UHFFFAOYSA-N

MDL Number (MFCD)

MFCD27244319

Chemical and Physical Properties

Saltdata

n/a

Molecular Weight

454.93

Hydrogen Bond Acceptors Count

11.00

Hydrogen Bond Donors Count

0.00

Rotatable Bond Count

5.00

Number of Nitrogen and Oxygen Atoms

9

Partition Coefficient, logP

2.813

Distribution Coefficient, logD

2.813

Water Solubility, LogSw

-3.41

Polar Surface Area

88.384

Acid Dissociation Constant (pKa)

20.11

Base Dissociation Constant (pKb)

-3.19

Number of Chiral Centers

0.00

Percent sp3 carbon bonding

52.60

L310-0464 in Drug Discovery

Included in Screening Libraries

3D-Pharmacophore Based Diversity Library (49813 compounds)

BRD4 Targeted Library (4534 compounds)

CNS MPO Library (28609 compounds)

Included in 1.7M Stock Database

Therapeutical areas:
  • Cancer
  • Hemic and lymphatic
  • Cardiovascular
  • Metabolic
  • Nervous system
Targets:
  • Others

References: we are preparing a list of scientific research reports with L310-0464 chemical compound. It will be published here after verification.

Frequently Asked Questions

How to purchase chemical compound L310-0464?
Check Price and Availability of L310-0464, then you can add required amount to the Shopping Cart. In the Shopping Cart you can again refine your selection. Once you are sure that it’s exactly what you want you can move forward with the Checkout (to pay online by credit card, or via PayPal), or Request a Quote.
What is the minimum amount of L310-0464 you sell to drug discovery company or institution?
Available from 1 mg in Glass Vials or 96-tube racks.
Delivery options for L310-0464
ChemDiv sends parcels with Express services (UPS, WC).
  • 1–2 days for small orders
  • 2–4 weeks for large selections
Delivery formats for L310-0464
  • 0.5–50 mg of dry powder sample in single glass vials, custom vials
  • DMSO solutions frozen 10μl–250μl@10mM (96 and 384 format)

Custom synthesis of L310-0464 available by request